AstraZeneca Thailand certified as Top Employer 2022 in Thailand and Asia Pacific

AstraZeneca (Thailand) Ltd. has been recognised as a 2022 Top Employer in Thailand and Asia Pacific by the Top Employers Institute. Being certified as a Top Employer showcases the organisation’s dedication to a better world of work. It exhibits through excellent staff-oriented policies, a life-long learning culture, and an inclusive workplace where employees can thrive and develop. 

James Teague, Country President, AstraZeneca (Thailand) Ltd., said: “I am delighted and proud to see AstraZeneca Thailand be awarded the Top Employer 2022 for the second consecutive year. We never stop pushing the boundaries of science to accelerate the delivery of life-changing medicines that create enduring value for patients and society in Thailand. Over the last two years, we have taken additional steps and implemented new policies and ways to ensure that our employees continue developing, supporting, and building inclusion and diversity in our organisation. We always put our employees at the heart of what we do. These initiatives have enabled AstraZeneca Thailand to be a great place to work.”

Top Employers Institute CEO David Plink says: “Reflecting on the demanding year that has, like the year before it, impacted organisations across the world, AstraZeneca Thailand has continued to show that it prioritises maintaining excellent people practices in their workplace. In the past year they continued to meet the challenges of the wider world of work while working determinedly to workforce. We are pleased to celebrate and applaud the organisations that have been certified as Top Employers this year.”   

The Top Employers Institute programme certifies organisations based on the participation and results of their HR Best Practices Survey. This survey covers 6 HR domains consisting of 20 topics such as People Strategy, Work Environment, Talent Acquisition, Learning, Well-being and Diversity & Inclusion and more.

AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.